Review Article
Volume 13 Issue 6 - 2021
Strategic Management of Autism Spectrum Disorder
Priya Joon1, Anil Kumar1* and Milind Parle2
1Pharmacology Division, University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh, India
2Pharmacology Division, Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar (Haryana), Residence: D-2, Pharmacy University (DPSRU), New Delhi, India
*Corresponding Author: Anil Kumar, Professor of Pharmacology, Pharmacology Division, University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh, India.
Received: May 01, 2021; Published: May 25, 2021


Autism spectrum disorder (ASD) is a complex, multi-factorial, neurodevelopmental disorder with a dynamic set of neuronal and behavioral abnormalities, which involves various systems of the body. A sharp rise in the incidence of ASD cases has been noted worldwide owing to the complex combination of increased awareness, broader diagnostic criteria, poor nutrition, various prenatal, perinatal and postnatal factors, genetic predisposition precipitated by adverse environmental conditions and gynecological interventions. ASD is not a single disorder but it encompasses a broad spectrum of disorders resulting from various genetic and non-genetic risk factors contributing independently as well as together. The co-occurrence of different disorders in ASD seems to be normal rather than the exception. Although no medicine has been recognized to treat ASD, several medicines have been proposed to ameliorate co-morbid conditions and are found to be the most efficacious in diminishing ASD-associated symptoms such as self-harm, aggressive episodes, irritability, unusual conduct, in-attention, anxiety, depression, hyperactivity and insomnia. Complementary therapies such as cognitive behavioral therapy, Speech therapy, music therapy, educational therapy, psychotherapy, occupational therapy and nutritional therapy have shown partial benefits when applied individually as per the specific needs of the child. Most importantly compassionate care coupled with assurance and reassurance by the parents and friends is crucial. No single therapy works completely for all kinds of patients. Different treatment approaches have been practiced to address different aspects of social behavior, communication deficits, physical disabilities, specific symptoms and co-morbidities. Therefore, designing appropriate routine and behavioral support by a psychotherapist tailored for each child as per its symptoms is essential for providing a comfortable life. Several substances targeting immune dysfunction, neuroinflammation, glutamate/GABA imbalance, NMDA receptors and neuropeptides are undergoing clinical trials with variable success. Stem cell therapy aimed at preventing neuro-degeneration, modulating the immune system and improving brain function is also being investigated. To help the unfortunate child and improve the quality of life of concerned families, an integrative approach combining drug therapy and non-drug therapy offers a great promise. However, along with the therapeutic management, the cooperation of family members backed by society is necessary for enhancing the quality of life of a child suffering from ASD.

Keywords: Autism; Drug Therapy; CBT; Nutrition; Strategic


  1. Joon Priya., et al. “What is Autism?” Pharmacological Reports (2021).
  2. Joon Priya., et al. “The interplay of protective and risk factors linked to autism”. Journal of Clinical Images and Medical Case Reports2 (2021): 1070.
  3. Edition Fifth. "Diagnostic and statistical manual of mental disorders”. The American Psychiatric Association 21 (2013).
  4. Brondino Natascia., et al. "Complementary and alternative therapies for autism spectrum disorder”. Evidence-Based Complementary and Alternative Medicine (2015).
  5. Bradshaw Jessica., et al. "Feasibility and effectiveness of very early intervention for infants at-risk for autism spectrum disorder: A systematic review”. Journal of Autism and Developmental Disorders3 (2015): 778-794.
  6. Klein Nadav and Kathi J Kemper. "Integrative approaches to caring for children with autism”. Current Problems in Pediatric and Adolescent Health Care6 (2016): 195-201.
  7. Makrygianni Maria K., et al. "The effectiveness of applied behavior analytic interventions for children with Autism Spectrum Disorder: A meta-analytic study”. Research in Autism Spectrum Disorders 51 (2018): 18-31.
  8. Weston Lisa., et al. “Effectiveness of cognitive behavioural therapy with people who have autistic spectrum disorders: A systematic review and meta-analysis”. Clinical Psychology Review 49 (2016): 41-54.
  9. Good Darren J., et al. "Contemplating mindfulness at work: An integrative review”. Journal of Management1 (2016): 114-142.
  10. Cachia Renee L., et al. “Mindfulness in individuals with autism spectrum disorder: a systematic review and narrative analysis”. Review Journal of Autism and Developmental Disorders2 (2016): 165-178.
  11. Wether by Amy M., et al. "Parent-implemented social intervention for toddlers with autism: an RCT”. Pediatrics6 (2014): 1084-1093.
  12. Gabriels Robin L., et al. "Randomized controlled trial of therapeutic horseback riding in children and adolescents with autism spectrum disorder”. Journal of the American Academy of Child and Adolescent Psychiatry7 (2015): 541-549.
  13. Benevides Teal W., et al. "Interventions to address health outcomes among autistic adults: A systematic review”. Autism 6 (2020): 1345-1359.
  14. Delli Christine K., et al. “Review on Vocational Training and Employment of Individuals with Autism Spectrum Disorder”. Journal of Educational and Developmental Psychology 2 (2016): 84-96.
  15. Maw Su Su and Chiyori Haga. "Effectiveness of cognitive, developmental, and behavioural interventions for Autism Spectrum Disorder in preschool-aged children: A systematic review and meta-analysis”. Heliyon9 (2018): e00763.
  16. Lyall Kristen., et al. “Maternal lifestyle and environmental risk factors for autism spectrum disorders”. International Journal of Epidemiology 2 (2014): 443-464.
  17. F Marti Luis. "Dietary interventions in children with autism spectrum disorders-an updated review of the research evidence”. Current Clinical Pharmacology 4 (2014): 335-349.
  18. Peretti S., et al. "Diet: the keystone of autism spectrum disorder?”. Nutritional Neuroscience12 (2019): 825-839.
  19. Herbert Martha R and Julie A Buckley. "Autism and dietary therapy: case report and review of the literature”. Journal of Child Neurology8 (2013): 975-982.
  20. Verpeut Jessica L., et al. “Ketogenic diet exposure during the juvenile period increases social behaviors and forebrain neural activation in adult Engrailed 2 null mice”. Physiology and Behavior 161 (2016): 90-98.
  21. Ruskin David N., et al. "Ketogenic diets improve behaviors associated with autism spectrum disorder in a sex-specific manner in the EL mouse”. Physiology and Behavior 168 (2017): 138-145.
  22. Ruskin David N., et al. "Ketogenic diet improves core symptoms of autism in BTBR mice”. PLoS One6 (2013): e65021.
  23. Mari-Bauset Salvador., et al. "Evidence of the gluten-free and casein-free diet in autism spectrum disorders: a systematic review”. Journal of Child Neurology12 (2014): 1718-1727.
  24. De Theije Caroline GM., et al. "Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management”. European Journal of Pharmacology 668 (2011): S70-S80.
  25. Reissmann Andreas., et al. "Gluten-free and casein-free diets in the treatment of autism”. Functional Foods in Health and Disease 8 (2014): 349-361.
  26. Neumeyer Ann M., et al. "Bone density in peripubertal boys with autism spectrum disorders”. Journal of Autism and Developmental Disorders 7 (2013): 1623-1629.
  27. Li Ya-Min., et al. "Maternal dietary patterns, supplements intake and autism spectrum disorders: A preliminary case-control study”. Medicine52 (2018): 13902.
  28. Li Yong-Jiang., et al. “Supplement intervention associated with nutritional deficiencies in autism spectrum disorders: a systematic review”. European Journal of Nutrition 7 (2018): 2571-2582.
  29. Saghazadeh Amene., et al. "Status of essential elements in autism spectrum disorder: systematic review and meta-analysis”. Reviews in the Neurosciences 7 (2017): 783-809.
  30. Pistollato Francesca., et al. "Pharmacological, non-pharmacological and stem cell therapies for the management of autism spectrum disorders: A focus on human studies”. Pharmacological Research 152 (2020): 104579.
  31. Dolske Michelle Cobb., et al. "A preliminary trial of ascorbic acid as supplemental therapy for autism”. Progress in Neuro-Psychopharmacology and Biological Psychiatry 5 (1993): 765-774.
  32. Saad Khaled., et al. "Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children”. Nutritional Neuroscience 8 (2016): 346-351.
  33. Bjørklund Geir., et al. "The role of vitamins in autism spectrum disorder: what do we know?”. Journal of Molecular Neuroscience 3 (2019): 373-387.
  34. Bent Stephen., et al. "A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder”. Journal of Autism and Developmental Disorders 5 (2011): 545-554.
  35. Yang, Yongshou., et al. “Targeting gut microbiome: A novel and potential therapy for autism”. Life Sciences 194 (2018): 111-119.
  36. Sivamaruthi Bhagavathi Sundaram., et al. "Probiotics in human mental health and diseases-A mini-review”. Tropical Journal of Pharmaceutical Research5 (2019): 889-895.
  37. Sivamaruthi Bhagavathi Sundaram., et al. "The role of microbiome, dietary supplements, and probiotics in autism spectrum disorder”. International Journal of Environmental Research and Public Health 8 (2020): 2647.
  38. Taliou Anilia., et al. "An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders”. Clinical Therapeutics5 (2013): 592-602.
  39. Singh Kanwaljit., et al. "Sulforaphane treatment of autism spectrum disorder (ASD)”. Proceedings of the National Academy of Sciences43 (2014): 15550-15555.
  40. Bhandari Ranjana and Anurag Kuhad. "Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders”. Life Sciences 141 (2015): 156-169.
  41. Bhandari Ranjana and Anurag Kuhad. "Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders”. Neurochemistry International 103 (2017): 8-23.
  42. Al-Ayadhi Laila Y., et al. "Behavioral benefits of camel milk in subjects with autism spectrum disorder”. Journal of College of Physicians and Surgeons Pakistan 11 (2015): 819-823.
  43. Zilkha Noga., et al. “High-fat diet exacerbates cognitive rigidity and social deficiency in the BTBR mouse model of autism”. Neuroscience 345 (2017): 142-154.
  44. Lane-Donovan., et al. “High-fat diet changes hippocampal apolipoprotein E (ApoE) in a genotype-and carbohydrate-dependent manner in mice”. PLoS One2 (2016): e0148099.
  45. Privett D. "Autism spectrum disorder-research suggests good nutrition may manage symptoms”. Today’s Dietitian1 (2013): 46-51.
  46. Cekici Hande and Nevin Sanlier. "Current nutritional approaches in managing autism spectrum disorder: A review”. Nutritional Neuroscience3 (2019): 145-155.
  47. Milind Parle and Arya Ashwani. "Music Therapy: a battery charger for human brain”. Asian Journal of Bio Science2 (2008): 381-388.
  48. Marquez-Garcia Amparo V., et al. "Music Therapy in Autism Spectrum Disorder: a Systematic Review”. Review Journal of Autism and Developmental Disorders (2021): 1-17.
  49. Mortimer Rachel., et al. “The effectiveness of hydrotherapy in the treatment of social and behavioral aspects of children with autism spectrum disorders: a systematic review”. Journal of Multidisciplinary healthcare 7 (2014): 93.
  50. Koenig Kristie Patten., et al. “Efficacy of the Get Ready to Learn yoga program among children with autism spectrum disorders: A pretest–posttest control group design”. American Journal of Occupational Therapy5 (2012): 538-546.
  51. Lee Myeong Soo., et al. “Massage therapy for children with autism spectrum disorders: a systematic review”. The Journal of Clinical Psychiatry3 (2010): 406-411.
  52. Lee Myeong Soo., et al. "Acupuncture for children with autism spectrum disorders: a systematic review of randomized clinical trials”. Journal of Autism and Developmental Disorders8 (2012): 1671-1683.
  53. Neely Leslie., et al. "Effects of antecedent exercise on academic engagement and stereotypy during instruction”. Behavior Modification1 (2015): 98-116.
  54. Pandina Gahan., et al. "Current Approaches to the Pharmacologic Treatment of Core Symptoms Across the Lifespan of Autism Spectrum Disorder”. Child and Adolescent Psychiatric Clinics2 (2020): 301-317.
  55. Lamy Martine., et al. "Recent advances in the pharmacological management of behavioral disturbances associated with autism spectrum disorder in children and adolescents”. Pediatric Drugs (2020): 1-11.
  56. Fortea Adriana., et al. "Long-acting injectable atypical antipsychotic use in adolescents: An observational study”. Journal of Child and Adolescent Psychopharmacology4 (2018): 252-257.
  57. Kassem Sara and Terry Oroszi. "Possible Therapeutic Use of Bumetanide in the Treatment of Autism Spectrum Disorder”. Journal of Biosciences and Medicines12 (2019): 58.
  58. Melamed Isaac R., et al. "A pilot study of high‐dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation”. Autism Research3 (2018): 421-433.
  59. Yatawara CJ., et al. "The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial”. Molecular Psychiatry9 (2016): 1225-1231.
  60. A study of balovaptan in adults with autism spectrum disorder with a 2-year open-label extension - Full Text View – ClinicalTrials (2018).
  61. Zamberletti Erica., et al. “The endocannabinoid system and autism spectrum disorders: insights from animal models”. International Journal of Molecular Sciences9 (2017): 1916.
  62. Joon Priya., et al. “Shatavari: a nature’s gift for autism”. Asian Journal of Bio Sciences1-2 (2019): 12-21.
  63. Joon Priya., et al. “Biochemical evidence for anti-autistic potential of Asparagus racemosus”. International Journal of Plant Sciences1 (2020): 42-51.
  64. Al-Gholam., et al. “The Neuroprotective Effect of Ginkgo Biloba Extract on Valproic Acid Induced Autistic Features in Mice”. Journal of Clinical and Diagnostic Research8 (2020).
  65. Gonzales Edson Luck T., et al. "Supplementation of Korean Red Ginseng improves behavior deviations in animal models of autism”. Food and Nutrition Research1 (2016): 29245.
Citation: Anil Kumar., et al. “Strategic Management of Autism Spectrum Disorder”. EC Neurology 13.6 (2021): 09-22.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 08, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to